. . . . . . . . . "\"ORILISSA is contraindicated in women: Who are pregnant [see Use in Specific Populations ( 8.1 With known osteoporosis because of the risk of further bone loss [see Warnings and Precautions ( 5.1 With severe hepatic impairment [see Use in Specific Populations ( 8.7 12.3 With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil) [see Drug Interactions ( 7.2 Pregnancy ( 4 Known osteoporosis ( 4 Severe hepatic impairment ( 4 Strong organic anion transporting polypeptide (OATP) 1B1 inhibitors ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "edrHP6jg06G2AtRoWIAYLdQD3o3l/CVCQyOIPCIAYJmN0BiUgLUd0WFNBAcsBI6b4f3GGV8BWr+m/aLmwhOwGQqfOJfoKtBBFHQ7NZCv677fvyW1X1duGwlCYMIgwiFxvCDOfKIUnBm1fTarng5YPnt9cPd7JGLC2gx0yovyEL0=" . . "2021-08-25T14:03:22.564+02:00"^^ . . . . .